Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2012.03.28
董事会关于审计机构2011年度审计事情的总结报告
2012.03.28
中国中投证券有限责任公司关于公司2012年度拟继续租赁关联方物业作为办公场合的核查意...
2012.03.28
关于无偿租用关联方物业的通告
2012.03.20
关于取得发明专利证书的通告
2012.03.08
2012年第一次暂时股东大会决议通告
2012.03.08
2012年第一次暂时股东大会的执法意见书
2012.03.07
关于全资子公司完成增资变换注册的通告
2012.02.18
2011年度业绩快报
2012.02.11
北京市中伦状师事务所关于公司股权激励妄想的执法意见书
2012.02.11
北京市中伦状师事务所关于公司股票期权激励妄想的增补执法意见书
第一页
上一页
131
132
133
134
135
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】